Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...
A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
5h
Hosted on MSNShows like ‘Breaking Bad’ to Satisfy Your Crime FixBreaking Bad remains one of the most beloved crime dramas to ever grace the television. This American classic debuted in ...
The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...
Netflix's new limited series retells the story of a wellness influencer who rejected traditional cancer treatments in favor ...
Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...
A federal appellate court has rejected the latest effort by a Washington State doctor who is seeking to legally use psilocybin to treat cancer patients in end-of-life care, ruling that the Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results